These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 179937

  • 1. Homologous passive cutaneous anaphylaxis (PCA) in mice and heterologous PCA induced in rats with mouse IgE.
    Braga F, Mota I.
    Immunology; 1976 May; 30(5):655-69. PubMed ID: 179937
    [Abstract] [Full Text] [Related]

  • 2. An analysis of the specificity in pharmacological inhibition of the passive cutaneous anaphylaxis reaction in mice and rats.
    Perper RJ, Oronsky AL, Blancuzzi V.
    J Pharmacol Exp Ther; 1975 May; 193(2):594-602. PubMed ID: 49417
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of myeloma IgE injections on passive and active cutaneous anaphylaxis in rats.
    Spiegelberg HL, Canning KM, Scheetz M, Koppel G, Chiller JM.
    J Immunol; 1986 Jan; 136(1):131-5. PubMed ID: 3484388
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inhibition of immediate hypersensitivity reactions in the rat by disodium cromoglycate and nitroindanedione.
    Spicer BA, Ross JW, Smith H.
    Clin Exp Immunol; 1975 Sep; 21(3):419-29. PubMed ID: 812623
    [Abstract] [Full Text] [Related]

  • 7. [Comparative antiallergic and anti-inflammatory action of F1865, mepyramine maleate, desonide and disodium cromoglycate after cutaneous administration].
    Tarayre JP, Aliaga M, Villanova G, Barbara M, Bru M, Caillol V, Lauressergues H.
    J Pharmacol; 1984 Sep; 15(1):37-51. PubMed ID: 6425568
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 1st communication: effects on type I to type IV allergic reactions in animal models.
    Yanagihara Y, Abe T, Edanami K, Agata M, Kuroda T, Shida T.
    Arzneimittelforschung; 1988 Jan; 38(1):70-4. PubMed ID: 2966629
    [Abstract] [Full Text] [Related]

  • 12. Mouse and rat IgE Cross-sensitization of mast cells and antigenic relationships.
    Prouvost-Danon A, Wyczolkowska J, Binaghi R, Abadie A.
    Immunology; 1975 Jul; 29(1):151-62. PubMed ID: 806516
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Regulation of allergic reactions by aerobic Corynebacterium equi extract, CEF. II. Inhibition of Heterologous PCA and antigen-induced histamine release in rats.
    Ezoe H, Furuichi K, Katoh H, Obara T.
    Int Arch Allergy Appl Immunol; 1981 Jul; 66(3):237-43. PubMed ID: 6170590
    [Abstract] [Full Text] [Related]

  • 20. Novel IgE peptide-based vaccine prevents the increase of IgE and down-regulates elevated IgE in rodents.
    Peng Z, Liu Q, Wang Q, Rector E, Ma Y, Warrington R.
    Clin Exp Allergy; 2007 Jul; 37(7):1040-8. PubMed ID: 17581197
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.